The results are consistent with earlier reports that AD patients had lower plasma levels of HDL-C and APOA-I, when compared to healthy controls, and that both HDL-C and APOA-I levels inversely correlated with cognitive impairment [35,36]. This evidence concerns the gene APOA1 and Alzheimer disease.